臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]

請輸入前幾個字:

顯示項目 711326-711375 / 2346260 (共46926頁)
<< < 14222 14223 14224 14225 14226 14227 14228 14229 14230 14231 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2018-09-10T18:06:04Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH
臺大學術典藏	2020-03-05T08:04:03Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Min-Shu Hsieh;Lee M.-R.;Keng L.-T.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; MIN-SHU HSIEH; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2020-08-13T06:33:37Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; JIN-YUAN SHIH
臺大學術典藏	2017	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2021-01-08T03:40:20Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG
臺大學術典藏	2021-03-11T07:58:31Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:29:35Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-10-04T07:15:44Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-01-08T02:56:48Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Li-Ta Keng;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2021-09-17T02:51:01Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2021-09-17T03:21:19Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	SHENG-KAI LIANG; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y.
中山醫學大學	2021	Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study	Su, PY; Su, WW; Hsu, YC; Huang, SP; Yen, HH
國立成功大學	2024	Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa	Hou;P, -C.;Aala;W;Tu;W, -T.;McGrath;J, A.;Hsu;C, -K.
國立成功大學	2023	Real-world experience on intravitreal dexamethasone implant in patients with macular edema scheduled to undergo cataract surgery	Lai, C.-C.;Kuo, S.-C.
臺大學術典藏	2021-05-06T01:25:13Z	Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study	Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group
臺大學術典藏	2021-08-16T08:36:11Z	Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study	Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group
臺大學術典藏	2021-08-20T07:10:55Z	Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study	Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group
國立成功大學	2021	Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study	Liou, B.-H.;Sun, H.-Y.;Yang, C.-J.;Syue, L.-S.;Lee, Y.-L.;Tang, H.-J.;Tsai, H.-C.;Lin, C.-Y.;Chen, T.-C.;Lee, C.-Y.;Huang, S.-H.;Liu, C.-W.;Lu, P.-L.;Lin, S.-P.;Wang, N.-C.;Cheng, A.;Ko, W.-C.;Cheng, S.-H.;Hung, C.-C.;Group, the Taiwan HIV Study
嘉南藥理大學	2021	Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study	Liou, Bo-Huang; Sun, Hsin-Yun; Yang, Chia-Jui; Syue, Ling-Shan; Lee, Yu-Lin; Tang, Hung-Jen; Tsai, Hung-Chin; Lin, Chi-Ying; Chen, Tun-Chieh; Lee, Chun-Yuan; Huang, Sung-Hsi; Liu, Chia-Wei; Lu, Po-Liang; Lin, Shih-Ping; Wang, Ning-Chi; Cheng, Aristine; Ko, Wen-Chien; Cheng, Shu-Hsing; Hung, Chien-Ching
臺大學術典藏	2020-03-05T06:05:32Z	Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan	LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H.
臺大學術典藏	2020-11-03T12:37:44Z	Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan	Li-Kai Tsai;Lin H.-J.;Chua S.-K.;Liao P.-C.;Yang Y.-P.;Chou P.-C.;Lee C.-W.;Lin M.-J.;Chen H.-M.;Yeh J.-T.;Li Y.-H.; LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H.
臺大學術典藏	2021-11-26T05:56:35Z	Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan	LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H.
國立成功大學	2018-02	Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan	Tsai;Li-Kai;Lin;Huey-Juan;Chua;Su-Kiat;Liao;Pen-Chih;Yang;Yuan-Po;Chou;Ping-Chen;Lee;Chun-Wei;Lin;Mao-Jen;Chen;Hsi-Ming;Yeh;Jung-Tze;Li;Yi-Heng
國家衛生研究院	2024-08-12	Real-world insights from comprehensive genomic profiling across multiple cancer types	Hung, LJ;Huang, CY;Chen, JS;Huang, WK;Hsu, CC;Fang, YF;Wang, CL;Liu, PC;Yeh, KY;Chang, PH;Chang, JWC;Lin, YC;Huang, SF;Chou, WC
臺大學術典藏	2021-08-15T00:08:17Z	Real-world insights into patients with advanced NSCLC and MET alterations	Bittoni, Marisa; CHIH-HSIN YANG; JIN-YUAN SHIH; Peled, Nir; Smit, Egbert F.; Camidge, D. Ross; Arasada, Rajeswara Rao; Oksen, Dina; Boutmy, Emmanuelle; Stroh, Christopher; Johne, Andreas; Carbone, David P.; Paik, Paul K.
臺大學術典藏	2021-11-03T02:33:00Z	Real-world insights into patients with advanced NSCLC and MET alterations	Bittoni M.; Yang J.C.-H.; JIN-YUAN SHIH; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K.
臺大學術典藏	2022-08-10T02:37:40Z	Real-world insights into patients with advanced NSCLC and MET alterations	Bittoni M.; CHIH-HSIN YANG; Shih J.-Y.; Peled N.; Smit E.F.; Camidge D.R.; Arasada R.R.; Oksen D.; Boutmy E.; Stroh C.; Johne A.; Carbone D.P.; Paik P.K.
臺大學術典藏	2022-02-22T05:34:08Z	Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis	Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏	2022-02-23T02:12:18Z	Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis	Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
國立交通大學	2019-04-03T06:37:18Z	Real-World Neuroimaging Technologies	McDowell, Kaleb; Lin, Chin-Teng; Oie, Kelvin S.; Jung, Tzyy-Ping; Gordon, Stephen; Whitaker, Keith W.; Li, Shih-Yu; Lu, Shao-Wei; Hairston, W. David
臺大學術典藏	2020-05-26T09:26:29Z	Real-World or Controlled Clinical Trial Data in Real-World Practice	Chih-Hsin Yang;Wu T.-H; Wu T.-H; CHIH-HSIN YANG
國立成功大學	2024-05-16	Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer	Chang;Gee-Chen;Shih;Jin-Yuan;Yu;Chong-Jen;Chao;Heng-Sheng;Yang;Cheng-Ta;Lin;Chien-Chung;Hung;Jen-Yu;Hsiao;Sheng-Yen;Wang;Chin-Chou;Chian;Chih-Feng;Hsia;Te-Chun;Chen;Yuh-Min
國立成功大學	2021-07	Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis	Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu
國立成功大學	2021-7	Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis	郭欣瑜; Kuo, Shi-Yu; Tsai, Hong-Ming;Han, Meng-Zhi;Lin, Yih-Jyh;Chang, Ting-Tsung;Chen, Chiung-Yu;Cheng, Pin-Nan;Chuang, Chiao-Hsiung;Wu, I-Chin;Chen, Po-Jun;Kang, Jui-Wen;Chiu, Yen-Cheng;Chiu, Hung-Chih;Chien, Shih-Chieh;Kuo, Hsin-Yu
國立成功大學	2019-10	Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment	Su;Po-Lan;Yang;Szu-Chun;Chen;Yi-Lin;Wu;Yi-Lin;Lin;Chia-Ying;Chang;Wei-Yuan;Tseng;Yau-Lin;Lai;Wu-Wei;Ho;Chung-Liang;Lin;Chien-Chung;Su;Wu-Chou
臺大學術典藏	2021-09-14T23:18:37Z	Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015	Wang, Chen Yu; Huang, Huai Hsuan; Chen, Ho Min; FEI-YUAN HSIAO; BOR-SHENG KO
臺大學術典藏	2022-09-19T03:16:34Z	Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015	Wang C.-Y.; Huang H.-H.; Chen H.-M.; FEI-YUAN HSIAO; Ko B.-S.
臺大學術典藏	2020-11-11T00:57:54Z	Real-world Outcomes of Ultrasonography-guided Interventions in a Tertiary Hospital	Liao, Yk;Shyu, Sg;Chueh-Hung Wu; Liao, YK; Shyu, SG; CHUEH-HUNG WU
臺大學術典藏	2021-01-21T02:52:29Z	Real-world outcomes of ultrasonography-guided interventions in a tertiary hospital	Liao Y.-K.; SHAW-GANG SHYU; Wu C.-H.
臺大學術典藏	2021-11-05T08:01:35Z	Real-world outcomes of ultrasonography-guided interventions in a tertiary hospital	Liao Y.-K.; SHAW-GANG SHYU; Wu C.-H.
臺大學術典藏	2021-05-27T02:50:07Z	Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)	Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I.
臺大學術典藏	2022-03-04T08:22:44Z	Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey)	Chuah Y.-Y.; Wu D.-C.; Chuah S.-K.; JYH-CHIN YANG; Lee T.-H.; Yeh H.-Z.; Chen C.-L.; Liu Y.-H.; Hsu P.-I.
國立臺灣海洋大學	2017	Real-World RESTful Service Composition: A Transformation-Annotation-Discovery Approach	Shang-Pin Ma;Hsuan-Ju Lin;Ci-Wei Lan;Wen-Tin Lee;Ming-Jen Hsu
國立臺灣海洋大學	2017	Real-World RESTful Service Composition: A Transformation-Annotation-Discovery Approach	Shang-Pin Ma;Hsuan-Ju Lin;Ci-Wei Lan;Wen-Tin Lee;Ming-Jen Hsu
國立成功大學	2021	Real-world results of immune checkpoint inhibitors from the taiwan national health insurance registration system	Hsieh, S.-T.;Ho, Ho H.-F.;Tai, H.-Y.;Chien, L.-C.;Chang, H.-R.;Chang, H.-P.;Huang, Y.-W.;Huang, J.-J.;Lien, H.-J.;Huang, L.-Y.;Lee, P.-C.
國立成功大學	2021	Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System	Hsieh;S-T;Ho;H-F;Tai;H-Y;Chien;L-C;Chang;H-R;Chang;H-P;Huang;Y-W;Huang;J-J;Lien;H-J;Huang;L-Y;Lee;P-C
臺大學術典藏	2020-03-05T05:37:43Z	Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation	Lin S.-Y.;Kuo C.-H.;Shin-Joe Yeh;Tsai L.-K.;Liu Y.-B.;Huang C.-F.;Tang S.-C.;Jeng J.-S.; Lin S.-Y.; Kuo C.-H.; SHIN-JOE YEH; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; Jeng J.-S.
臺大學術典藏	2020-11-03T11:07:55Z	Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation	Lin S.-Y.;Kuo C.-H.;Yeh S.-J.;Tsai L.-K.;Liu Y.-B.;Huang C.-F.;Sung-Chun Tang;Jeng J.-S.; Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; SUNG-CHUN TANG; Jeng J.-S.
臺大學術典藏	2021-12-22T03:53:44Z	Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation	Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; Liu Y.-B.; Huang C.-F.; Tang S.-C.; JIANN-SHING JENG

顯示項目 711326-711375 / 2346260 (共46926頁)
<< < 14222 14223 14224 14225 14226 14227 14228 14229 14230 14231 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2853524
	造訪人次 : 45210263 線上人數 : 728 教育部委託研究計畫計畫執行:國立臺灣大學圖書館